Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Plastic and Reconstructive Surgery. Global Open|March 23, 2026
Adverse Event Reports and Safety Measures for Breast Implant-associated Anaplastic Large Cell Lymphoma in JapanKoko Akaishi, Hideki MaedaYakushigaku Zasshi|March 25, 2015
[The history of developing anticancer Drugs and their evaluation guidelines in Japan]Hideki Maeda, Tatsuo KurokawaInternational Journal of Clinical Oncology|April 4, 2015
Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?Hideki Maeda, Tatsuo KurokawaInternational Journal of Clinical Oncology|August 6, 2025
A cross-sectional study on the first-in-human trials of anticancer drugs in Japan and the United States and the probability of approvalAkari Mukaida, Hideki MaedaFrontiers in Medicine|May 2, 2022
Regulatory Approval With Real-World Data From Regulatory Science Perspective in JapanHideki Maeda, Daniel Bin NgClinical and Translational Science|June 8, 2026
Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug DevelopmentKeiko Yamamoto, Aya Iwase, Hideki MaedaScientific Reports|June 2, 2025
Potential surrogate endpoint for B-cell hematologic malignancy: A systematic review and meta-analysisSatoshi Hirano, Keisuke Hanada, Hideki MaedaFrontiers in Medicine|July 1, 2026
Correction: Current situation and issues regarding termination of risk management plans in JapanNatsuko Kameyama, Aoi Hosaka, Hideki MaedaFrontiers in Medicine|November 13, 2024
Has risk management plan system influenced the speed of package insert revisions in Japan?Natsuko Kameyama, Aoi Hosaka, Hideki MaedaPatient Preference and Adherence|July 16, 2024
A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in JapanHaruto Hayashi, Takehide Nogita, Hideki MaedaPageof 8